China Sinovac doubles output pace to 2bn jabs annuallyEuropost
The Covid-19 vaccine race is entering a new phase as pharmaceutical companies struggle to boost their output capacity, while governments negotiate and enforce the jabs rollout, Reuters reported. The Chinese Sinovac announced it had robust demand for Covid-19 jabs and thus seeks for ways to increase production capacity.
Sinovac Biotech confirmed its third production plant was ready and had started manufacturing procedures for bulk vaccine ingredient, doubling its annual capacity to 2 billion doses. A Sinovac spokesman said the third facility, in Beijing, had started cultivating cells where the coronavirus would be grown, a procedure that could take a relatively long time. Sinovac did not say when it will actually produce 2 billion doses of the vaccine. More than 200 million doses of Sinovac's vaccine named CoronaVac have been delivered globally, up from 160 million doses announced on 22 March. The firm said it estimated over 100 million doses have been administered worldwide.